Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aldeyra Therapeutics, Inc. | Director | Common Stock | 14.8K | $25.8K | $1.74 | Sep 7, 2023 | Direct |
Aldeyra Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 2.6K | Jun 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALDX | Aldeyra Therapeutics, Inc. | Jun 4, 2024 | 3 | $0 | 4 | Jun 6, 2024 | Director |
ALDX | Aldeyra Therapeutics, Inc. | Sep 7, 2023 | 2 | $3K | 4 | Sep 11, 2023 | Director |
ALDX | Aldeyra Therapeutics, Inc. | Jun 30, 2023 | 3 | $0 | 4 | Jul 5, 2023 | Director |
ALDX | Aldeyra Therapeutics, Inc. | Jun 7, 2022 | 3 | $0 | 4 | Jun 9, 2022 | Director |
ALDX | Aldeyra Therapeutics, Inc. | Jun 8, 2021 | 3 | $0 | 4 | Jun 10, 2021 | Director |